Acylaminoindole derivatives as 5-ht1 agonists
US5498626A · kind A · utility
Assignee
Inventor
Key dates
| Filing date | Sep 14, 1994 |
| Grant date | Mar 12, 1996 |
| Priority date | — |
| Expiry date | Sep 14, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
##STR1## Compounds of formula (I) where n is 0, 1, or 2; m is 0 or 1; Y and W are each an amino acid residue; R.sub.1 is hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.3 -C.sub.6 alkenyl, C.sub.3 -C.sub.6 alkynyl, aryl, C.sub.1 -C.sub.3 alkylaryl, or C.sub.1 -C.sub.3 alkylheteroaryl, and --(CH.sub.2).sub.p R.sub.3 ; R.sub.2 is CF.sub.3, C.sub.1 -C.sub.6 alkyl, aryl, C.sub.1 -C.sub.3 alkylaryl, and --OR.sub.5 ; R.sub.3 is cyano, trifluoromethyl, or --OR.sub.4 ; R.sub.4 is hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.3 alkylaryl, or aryl; R.sub.5 is C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.3 alkylaryl, or aryl; R.sub.6 is hydrogen, --OR.sub.7, or --NHCOR.sub.7 ; R.sub.7 is hydrogen, C.sub.1 to C.sub.6 alkyl, aryl or C.sub.1 to C.sub.3 alkyl-aryl; p is 1, 2, or 3; and the above aryl groups and the aryl moieties of the above alkyl-aryl groups are independently selected from phenyl and substituted phenyl, wherein said substituted phenyl may be substituted with one to three groups selected from C.sub.1 to C.sub.4 alkyl, halogen, hydroxy, cyano, carboxamide, nitro, and C.sub.1 to C.sub.4 alkoxy and the pharmaceutically acceptable salts thereof. These compounds are useful in treating migraine a…
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.